Atrial cardiopathy and stroke

Mitchell S. V. Elkind

doi:10.1055/s-0042-1758385

Arquivos de Neuro-Psiquiatria, Table of Contents

CC BY 4.0 · Arq Neuropsiquiatr 2022; 80(09): 875-876
DOI: 10.1055/s-0042-1758385

Editorial

Atrial cardiopathy and stroke

Cardiopatia atrial e acidente vascular cerebral

Authors

Mitchell S. V. Elkind

¹Columbia University, Vagelos College of Physicians and Surgeons, Department of Neurology, New York, United States.

²Columbia University, Mailman School of Public Health, Department of Epidemiology, New York, United States.

Abstract

Full Text

References

References
1 Sanna T, Diener HC, Passman RS. et al; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370 (26) 2478-2486
2 Bernstein RA, Kamel H, Granger CB. et al; STROKE-AF Investigators. Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. JAMA 2021; 325 (21) 2169-2177
3 Thijs VN, Brachmann J, Morillo CA. et al. Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF. Neurology 2016; 86 (03) 261-269
4 Wasser K, Weber-Krüger M, Gröschel S. et al. Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke: A Subanalysis of the Find-AF_RANDOMISED Trial. Stroke 2020; 51 (02) 395-401
5 Çinar T, Hayiroglu MI, Selçuk M. et al. Evaluation of Electrocardiographic P Wave Parameters in Predicting Long-term Atrial Fibrillation in Patients with Acute Ischemic Stroke. Arq. Neuropsiquiatr. 2022; 80 (09) 877-884
6 Brambatti M, Connolly SJ, Gold MR. et al; ASSERT Investigators. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 2014; 129 (21) 2094-2099
7 Yaghi S, Moon YP, Mora-McLaughlin C. et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke 2015; 46 (06) 1488-1493
8 Kamel H, Bartz TM, Elkind MSV. et al. Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study). Stroke 2018; 49 (04) 980-986
9 Longstreth Jr WT, Kronmal RA, Thompson JL. et al. Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke 2013; 44 (03) 714-719
10 Healey JS, Gladstone DJ, Swaminathan B. et al. Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial. JAMA Neurol 2019; 76 (07) 764-773
11 Kamel H, Longstreth Jr WT, Tirschwell DL. et al. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. Int J Stroke 2019; 14 (02) 207-214